Authorisation no cure to cartel risks posed by pharmaceutical patent settlement agreements
29 August 2022
After much anticipation, the Australian Competition and Consumer Commission (ACCC) has recently issued a draft determination indicating it proposed to deny an application for authorisation of conduct in connection with a pharmaceutical settlement and licence agreement.
Read on